Skip to main content
Trevor Gerson, MD, Neurology, Kansas City, MO

Trevor Gerson MD

Headache


Headache Neurologist

Join to View Full Profile
  • 2401 Gillham RoadKansas City, MO 64108

Dr. Gerson is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Children's Mercy Kansas City
    Children's Mercy Kansas CityNeurology, 2020
  • University of Missouri-Kansas City School of Medicine
    University of Missouri-Kansas City School of MedicineFellowship, Neurology, 2020
  • University of Kansas School of Medicine
    University of Kansas School of MedicineResidency, Neurology, 2015 - 2019
  • Chicago Medical School at Rosalind Franklin University of Medicine and Science
    Chicago Medical School at Rosalind Franklin University of Medicine and ScienceClass of 2015

Certifications & Licensure

  • MO State Medical License
    MO State Medical License 2019 - 2026
  • KS State Medical License
    KS State Medical License 2015 - 2025
  • Neurology
    American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

  • Gold Humanism Award Gold Humanism Honors Society, 2015

Publications & Presentations

PubMed

Press Mentions

  • Nerivio Device Cleared for Pediatric Migraine Treatment
    Nerivio Device Cleared for Pediatric Migraine TreatmentNovember 15th, 2024
  • FDA Expands the Age Indication for Nerivio® as the First-and-Only REN Wearable for Migraine Treatment for Children Aged Eight and Above
    FDA Expands the Age Indication for Nerivio® as the First-and-Only REN Wearable for Migraine Treatment for Children Aged Eight and AboveNovember 14th, 2024
  • New Study Evaluates Use of the Nerivio® REN Wearable for Treatment of Migraine in Children Under the Age of 12
    New Study Evaluates Use of the Nerivio® REN Wearable for Treatment of Migraine in Children Under the Age of 12July 25th, 2024
  • Join now to see all

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: